Related Experiment Video
Updated: Jul 20, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
NPC1L1: evolution from pharmacological target to physiological sterol transporter
Murray W Huff1, Rebecca L Pollex, Robert A Hegele
1Vascular Biology Group, Robarts Research Institute, London, Ontario, Canada.
Arteriosclerosis, Thrombosis, and Vascular Biology
|September 16, 2006
Summary
Niemann-Pick C1-like 1 protein (NPC1L1) is key for cholesterol absorption and a target for drugs like ezetimibe. Studying NPC1L1 reveals insights into sterol metabolism and drug response phenotypes.
Area of Science:
- Biochemistry
- Pharmacology
- Human Genetics
Background:
- Niemann-Pick C1-like 1 protein (NPC1L1) is identified as the molecular target for cholesterol absorption inhibitors.
- Ezetimibe is a prominent drug in this class, targeting NPC1L1.
- NPC1L1 plays a crucial physiological role in the intestinal absorption of sterols, including cholesterol and plant sterols.
Purpose of the Study:
- To elucidate the physiological role of NPC1L1 in sterol absorption.
- To explore the association between NPC1L1 sequence variation and metabolic phenotypes.
- To understand NPC1L1's role in drug response phenotypes.
Main Methods:
- Human, animal, and cell-based functional studies.
- Human genetics approaches to analyze NPC1L1 sequence variation.
- Pharmacological studies using cholesterol absorption inhibitors.
Main Results:
- NPC1L1 is confirmed as the molecular target of cholesterol absorption inhibitors.
- NPC1L1's significant role in intestinal sterol absorption is established.
- Genetic variations in NPC1L1 correlate with metabolic and drug-response phenotypes.
Conclusions:
- Elucidating NPC1L1's function provides critical understanding of a key physiological pathway in sterol metabolism.
- NPC1L1 is a pivotal protein linking cholesterol absorption, sterol metabolism, and drug efficacy.
- Human genetics offers a powerful tool for dissecting complex metabolic pathways and drug interactions.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...